CARVEDILOL, A NEW NONSELECTIVE BETA-BLOCKER WITH INTRINSIC ANTI ALPHA-ADRENERGIC ACTIVITY, HAS A GREATER PORTAL HYPOTENSIVE EFFECT THAN PROPRANOLOL IN PATIENTS WITH CIRRHOSIS
R. Banares et al., CARVEDILOL, A NEW NONSELECTIVE BETA-BLOCKER WITH INTRINSIC ANTI ALPHA-ADRENERGIC ACTIVITY, HAS A GREATER PORTAL HYPOTENSIVE EFFECT THAN PROPRANOLOL IN PATIENTS WITH CIRRHOSIS, Hepatology, 26(4), 1997, pp. 17-17